Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when ChronoScale Holdings Corp publishes a filing, an earnings call transcript or a press release.

Get CHRN alerts

About Scott Davis

Scott Davis is recorded as CEO and COO at ChronoScale Holdings Corp (CHRN). ChronoScale Holdings Corp reported in an 8-K filed October 6, 2026 that Scott Davis resigned as member of the Board of Directors, effective October 3, 2026. ChronoScale Holdings Corp reported in an 8-K filed December 5, 2022 that Scott Davis was appointed Chief Executive Officer, effective December 5, 2022. The proxy statement of ChronoScale Holdings Corp reports total compensation of $473,017 for Scott Davis in fiscal 2024, including a base salary of $375,000. Disclosed compensation is on record for 3 fiscal years. Scott Davis has spoken on 15 earnings calls across 1 company, most recently for ChronoScale Holdings Corp on July 28, 2025. ChronoScale Holdings Corp is classified in the Information Technology Services industry within the Technology sector. Other leadership on record at ChronoScale Holdings Corp includes Ying Cenly Chen (CEO and Board Member), Wes Cummins (Chairman), Jerome Wong (CFO) and 7 others.

“Scott Davis, a member of the Board of Directors of the Company (the "Board") and Chief Executive Officer ("CEO") of Ekso, resigned from his position as a member of the Board, effective as of October 3, 2026.”
ChronoScale Holdings Corp Form 8-K, filed October 6, 2026 · Read the filing
“the Ekso Bionics Board of Directors appointed Mr. Davis as Chief Executive Officer, each effective immediately.”
ChronoScale Holdings Corp Form 8-K, filed December 5, 2022 · Read the filing

Scott Davis on recent calls

“Our second quarter revenues were disappointing. But as Jerome noted, we believe this was a temporary setback, driven mostly by short-term delays in completing 2 significant multiunit Enterprise Health device sales that were anticipated in the quarter.”
CEO, ChronoScale Corp Q2 FY2025 Earnings Call ·
“While we saw some softness in our legacy enterprise business in Q1 as we had several customers whose capital budgets were at least temporarily impacted by reactions to macroeconomic uncertainties, that was partially offset by good growth from our Ekso Indigo Personal.”
CEO, ChronoScale Corp Q1 FY2025 Earnings Call ·
“While we're pleased to achieve record revenue in the 2024 fourth quarter, in many respects, our primary focus throughout those three months was on the future, particularly for Ekso Indigo Personal.”
CEO, ChronoScale Corp Q4 FY2024 Earnings Call ·
“The third quarter reflected a period of transition in progress, particularly within our personal line of EksoHealth devices.”
CEO, ChronoScale Corp Q3 FY2024 Earnings Call ·
“We kicked off the second quarter on a positive note with our at-home Ekso Indego Personal device receiving a payment decision from CMS for lump-sum Medicare reimbursement and continued the momentum throughout the quarter by generating record quarterly sales in our EksoHealth segment.”
CEO, ChronoScale Corp Q2 FY2024 Earnings Call ·

Affiliation history

Company network

Leadership on record at ChronoScale Holdings Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 ChronoScale Holdings Corp (CHRN) $375,000 $473,017
2023 ChronoScale Holdings Corp (CHRN) $375,000 $637,020
2022 ChronoScale Holdings Corp (CHRN) $370,151 $1,069,804

Recent activity

Show 5 earlier activities